Positron emission tomography reporter gene imaging in the myocardium: For monitoring of angiogenic gene therapy in ischemic heart disease

Journal of Cardiac Surgery

Volumn 20, Issue SUPPL. 6, 2005, Pages

  Inubushi, Masayuki ^a   Tamaki, Nagara ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ANGIOGENIC PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA;

CLINICAL RESEARCH; CONFERENCE PAPER; GENE EXPRESSION; GENE THERAPY; HEART MUSCLE; ISCHEMIC HEART DISEASE; POSITRON EMISSION TOMOGRAPHY; REPORTER GENE;

GENE THERAPY; GENES, REPORTER; GENETIC VECTORS; HEART; HUMANS; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NEOVASCULARIZATION, PATHOLOGIC; POSITRON-EMISSION TOMOGRAPHY; PROMOTER REGIONS (GENETICS);

EID: 28444464203     PISSN: 08860440     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8191.2005.00152.x     Document Type: Conference Paper

References (36)

1. Bourassa MG, Holubkov R, Yeh W, et al: Strategy of complete revascularization in patients with multivessel coronary artery disease (a report from the 1985-1986 NHLBI PTCA Registry). Am J Cardiol 1992;70:174-178.
2. Mukherjee D, Bhatt DL, Roe MT, et al: Direct myocardial revascularization and angiogenesis-How many patients might be eligible? Am J Cardiol 1999;84:598-600, A8.
3. Freedman SB, Isner JM: Therapeutic angiogenesis for ischemic cardiovascular disease. J Mol Cell Cardiol 2001:33:379-393.
4. Hammond HK, McKirnan MD: Angiogenic gene therapy for heart disease: A review of animal studies and clinical trials. Cardiovasc Res 2001;49:561-567.
5. Rubanyi GM: The future of human gene therapy. Mol Aspects Med 2001;22:113-142.
6. Isner JM: Myocardial gene therapy. Nature 2002;415:234-239.
7. Cherry SR, Shao Y, Silverman RW, et al: MicroPET: A high resolution PET scanner for imaging small animals. IEEE Trans Nucl Sci 1997;44:1161-1166.
8. Tai YC, Chatziioannou AF, Yang Y, et al: MicroPET II: Design, development and initial performance of an improved microPET scanner for small-animal imaging. Phys Med Biol 2003:48:1519-1537.
9. Tjuvajev JG, Stockhammer G, Desai R, et al: Imaging the expression of transfected genes in vivo. Cancer Res 1995:55:6126-6132.
10. Tjuvajev JG, Finn R, Watanabe K, et al: Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: A potential method for monitoring clinical gene therapy. Cancer Res 1996:56:4087-4095.
11. Gambhir SS, Barrio JR, Wu L, et al: Imaging of adenoviral-directed herpes simplex virus type 1 thymidine kinase reporter gene expression in mice with radiolabeled ganciclovir. J Nucl Med 1998:39:2003-2011.
12. Wu JC, Tseng JR, Gambhir SS: Molecular imaging of cardiovascular gene products. J Nucl Cardiol 2004:11:491-505.
13. Casadaban MJ, Cohen SN: Lactose genes fused to exogenous promoters in one step using a Mu-lac bacteriophage: In vivo probe for transcriptional control sequences. Proc Natl Acad Sci USA 1979:76:4530-4533.
14. 18F]FHBG) : A new potential imaging agent for viral infection and gene therapy using PET. Nucl Med Biol 1998:25:175-180.
15. Jang SK, Pestova TV, Hellen CU, et al: Cap-independent translation of picornavirus RNAs: Structure and function of the internal ribosomal entry site. Enzyme 1990:44:292-309.
16. Wu JC, Inubushi M, Sundaresan G, et al: Positron emission tomography imaging of cardiac reporter gene expression in living rats. Circulation 2002:106:180-183.
17. Inubushi M, Wu JC, Gambhir SS, et al: Positron-emission tomography reporter gene expression imaging in rat myocardium. Circulation 2003:107:326-332.
18. Wu JC, Chen IY, Wang Y, et al: Molecular imaging of the kinetics of vascular endothelial growth factor gene expression in ischemic myocardium. Circulation 2004:110:685-691.
19. Carmeliet P, Collen D: Transgenic mouse models in angiogenesis and cardiovascular disease. J Pathol 2000:190:387-405.
20. Inubushi M, Jordan MC, Roos KP, et al: Nitrogen-13 ammonia cardiac positron emission tomography in mice: Effects of clonidine-induced changes in cardiac work on myocardial perfusion. Eur J Nucl Med Mol Imaging 2004:31:110-116.
21. Inubushi M, Harpf AE, Dahlbom M, et al: Noninvasive measurement of experimental myocardial infarctions in mice using microPET polar maps. J Nucl Med 2003:44:87P-88P (abstract).
22. Whitlock PR, Hackett NR, Leopold PL, et al: Adenovirus-mediated transfer of a minigene expressing multiple isoforms of VEGF is more effective at inducing angiogenesis than comparable vectors expressing individual VEGF cDNAs. Mol Ther 2004;9:67-75.
23. Kleiman NS, Patel NC, Allen KB, et al: Evolving revascularization approaches for myocardial ischemia. Am J Cardiol 2003;92:9N-17N.
24. Stolberg SG: The biotech death of Jesse Gelsinger. N Y Times Mag 1999:136-140, 149-150.
25. Wolff JA, Malone RW, Williams P, et al: Direct gene transfer into mouse muscle in vivo. Science 1990:247:1465-1468.
26. Tsurumi Y, Takeshita S, Chen D, et al: Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circulation 1996;94:3281-3290.
27. Hedman M, Hartikainen J, Syvanne M, et al: Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: Phase II results of the Kuopio Angiogenesis Trial (KAT). Circulation 2003:107:2677-2683.
28. Chu D, Thistlethwaite PA, Sullivan CC, et al: Gene delivery to the mammalian heart using AAV vectors. Methods Mol Biol 2004;246:213-224.
29. Grines CL, Watkins MW, Helmer G, et al Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris. Circulation 2002:105:1291-1297.
30. Grines CL, Watkins MW, Mahmarian JJ, et al: A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina. J Am Coll Cardiol 2003:42:1339-1347.
31. Folkman J: Clinical applications of research on angiogenesis. N Engl J Med 1995:333:1757-1763.
32. Aiello LP, Avery RL, Arrigg PG, et al: Vascular endothelial growth factor in ocular fluids of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994:331:1480-1487.
33. Moulton KS, Heller E, Konerding MA, et al: Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation 1999:99:1726-1732.
34. Phillips MI, Tang Y, Schmidt-Ott K, et al: Vigilant vector: Heart-specific promoter in an adeno-associated virus vector for cardioprotection. Hypertension 2002:39:651-655.
35. Tang Y, Jackson M, Qian K, et al: Hypoxia inducible double plasmid system for myocardial ischemia gene therapy. Hypertension 2002:39:695-698.
36. Springer ML, Chen AS, Kraft PE, et al: VEGF gene delivery to muscle: Potential role for vasculogenesis in adults. Mol Cell 1998:2:549-558.